Skip Navigation

A phase 1/2 study of CPX-351 (NSC#775341) Alone followed by Fludarabine, Cytarabine and G-CSF (FLAG) for Children with Relapsed Acute Myeloid Leukemia (AML)

Brief Summary


Study Type:

I/II Identifier:

Study #:
CMH - AAML1421

Start Date:
Jan 01, 0001

Full Details and Eligibility at

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below. ID: NCT02642965

View Complete Trial Details & Eligibility at